TABLE 1.
Summary of the major peptides against breast cancer with respective targets.
| Peptide | Sequence | Target/Ref. |
|---|---|---|
| P37 | LNVSRETLQQHKLLKVIRKKLVRKTLDMIKKIADDKY | gp96 Liang et al. (2021) |
| RGD/RGDK-octa-arginine | RGD/RGDK-octa-R | Integrin Garate et al. (2015); Hazeri et al. (2022) |
| TT1 | AKRGARSTA | gC1q Simón-Gracia et al. (2018)) |
| tLyP-1/CK3 | CGNKRTR/CLKADKAKC | neuropilin-1 Zhu et al. (2018); Feng et al. (2014) |
| p160/p18 | VPWMEPAYQRFL/WXEAAYQRFL | keratin 1 Askoxylakis et al. (2005); Shahin et al. (2013) |
| G3-C12 | ANTPCGPYTHDCPVKR | galectin-3 Kumar and Deutscher (2008) |
| 12a/13 | HKIKHRLLQ/Rcyclo (DILDap) RLLQ | ER Zhao et al. (2016) |
| DH6/RDH6/KAAYSL/HER2pep/A9/LTVSPWY/51 | YLFFVFER/REFVFFLY/KAAYSL/YCDGFYACYMDV/WAVQNTDAV/LTVSPWY/ATWLPVPVVGYFMASA | HER2 Du et al. (2020); Kim et al. (2020); Stefanick et al. (2015); Honarvar et al. (2018); Larimer et al. (2014) |
| 1-D03/GE11 | MEGPSKCCYSLALSH/YHWYGYTPQNVI | EGFR Larimer et al. (2014); Hailing et al. (2022) |